| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,092 |
15,739 |
$1.16M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,769 |
2,724 |
$277K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,076 |
2,034 |
$228K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,879 |
1,869 |
$187K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
6,405 |
6,311 |
$173K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,141 |
3,112 |
$123K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
794 |
786 |
$111K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,134 |
1,114 |
$110K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,039 |
1,031 |
$96K |
| G9153 |
Mapcp demonstration - physician incentive pool |
1,395 |
1,389 |
$67K |
| 92081 |
|
2,427 |
2,417 |
$61K |
| 90461 |
|
2,023 |
2,000 |
$49K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
386 |
385 |
$34K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,670 |
3,629 |
$29K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
132 |
130 |
$26K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,813 |
1,787 |
$23K |
| 96127 |
|
2,759 |
2,729 |
$19K |
| 97803 |
|
1,585 |
1,566 |
$14K |
| 92552 |
|
995 |
988 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
471 |
385 |
$9K |
| 99177 |
|
1,356 |
1,345 |
$6K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
343 |
342 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
49 |
48 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
73 |
71 |
$4K |
| 94760 |
|
2,631 |
2,450 |
$3K |
| 87634 |
|
35 |
33 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
121 |
119 |
$2K |
| 99384 |
|
12 |
12 |
$1K |
| 99051 |
|
75 |
71 |
$852.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
18 |
18 |
$595.00 |
| 97802 |
|
39 |
39 |
$455.20 |
| 81003 |
|
162 |
156 |
$388.93 |
| 90677 |
|
55 |
53 |
$288.66 |
| 83655 |
|
12 |
12 |
$165.48 |
| 36415 |
Collection of venous blood by venipuncture |
12 |
12 |
$24.67 |
| 90647 |
|
603 |
601 |
$0.00 |
| 90723 |
|
446 |
444 |
$0.00 |
| 90656 |
|
60 |
60 |
$0.00 |
| 90686 |
|
900 |
893 |
$0.00 |
| 90696 |
|
86 |
86 |
$0.00 |
| 90716 |
|
49 |
49 |
$0.00 |
| 90670 |
|
686 |
684 |
$0.00 |
| 90734 |
|
500 |
488 |
$0.00 |
| 90710 |
|
130 |
130 |
$0.00 |
| 90649 |
|
770 |
754 |
$0.00 |
| 90633 |
|
437 |
434 |
$0.00 |
| 90707 |
|
61 |
61 |
$0.00 |
| 90715 |
|
459 |
454 |
$0.00 |
| 90681 |
|
50 |
50 |
$0.00 |
| 90700 |
|
14 |
14 |
$0.00 |